health
1 min read
Medicare Expands Access for Weight Loss Drugs to Some Beneficiaries
Medicare has created a pathway for certain beneficiaries to access weight loss medications. This development follows a notable increase in the number of adults reporting GLP-1 drug usage for weight loss.
07/24/2026 · Alaska edition
Advertisement
Advertisement
Why it matters locally: The expansion of Medicare access to GLP-1 medications for weight loss will directly affect Alaska's eligible Medicare beneficiaries, providing potential new treatment options for obesity and related health conditions.
The utilization of GLP-1 medications for weight loss has shown an increase among American adults. A new Gallup poll indicates that 11% of adults currently use one of these drugs. This represents a significant rise from two years prior, when 3% of adults reported using them. Medicare has now made it possible for some patients to obtain these medications. William Brangham discussed these developments with Juliette Cubanski.Related Topics
Editorial Transparency
AI-Generated · Written by National DeskArticle Ratings
Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0
How do you feel about this story?
NA
National Desk
Trust 3.1104108 articles8,220,515 views75% fact accuracy
View ProfileSign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!